Clinical Trial Update: A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus Infection [Phase 4]

View source ↗

Summary

Phase IV trial update for a combination regimen (paritaprevir/ritonavir, ombitasvir, dasabuvir) in chronic Hepatitis C genotype 1 infection; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Paritaprevir/ritonavir, Ombitasvir, Dasabuvir

Snippet

Sponsor: Kirby Institute | Conditions: Hepatitis C, Chronic | Phase 4 | Status: COMPLETED